Business Practice

View More Business Development Legal Policy Practice Regulatory

Business Development Legal Policy Practice Regulatory

All Videos Insights Interviews Peer Exchange Podcasts

Gastroenterology

Dermatology Endocrinology Gastroenterology Legal Neurology Oncology Ophthalmology Rare Disease Rheumatology

Conference Coverage

Conference Listing

Conference Coverage Conference Listing

Biosimilar Resources

Authors Biosimilar Resources Polls

Subscribe BIOSIMILAR APPROVALS

About
Contact
Advisory Board
Do Not Sell My Information
Terms & Conditions
Privacy Policy

© 2022 MJH Life Sciences and Center for Biosimilars®. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Business PracticeSee All >

Business
Development
Legal
Policy
Practice
Regulatory

About
Contact
Advisory Board
Do Not Sell My Information
Terms & Conditions
Privacy Policy

© 2022 MJH Life Sciences^™ and Center for Biosimilars®. All rights reserved.

AAAAI Annual Meeting

home

Omalizumab Biologic is Changing the Face of Asthma Therapeutics

March 20th 2017

Dupilumab Improves Signs and Symptoms of Atopic Dermatitis Without Safety Issues

March 16th 2017

Fewer AEs With Humanized Antibody Treatments Favorable for Biosimilar Development

March 15th 2017

Case Study Indicates IVIG May Counteract Adalimumab

March 14th 2017

Dexpramipexole Lowers Blood and Tissue Eosinophils Without Severe Adverse Reactions

March 14th 2017